Preliminary experiments indicate conolidine may inhibit particular ion channels, cutting down neuronal excitability and limiting pain indicators. This mechanism is particularly applicable in neuropathic soreness, where abnormal signaling results in persistent discomfort. Also, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to suffering perception. Compu... https://franko592wxj5.blogoxo.com/profile